70 likes | 88 Views
A new study using GlycoCheck from Microvascular Health Solutions reveals that COVID-19 patients have severe damage to microcirculation and the endothelial glycocalyx.
E N D
Study Reveals COVID-19 Patients Suffer Severe Damage to the Endothelial Glycocalyx
A new study using GlycoCheck from Microvascular Health Solutions reveals that COVID-19 patients have severe damage to microcirculation and the endothelial glycocalyx. The study, Microvascular Dysfunction in COVID-19 Patients: MYSTIC Study, was released by Angiogenesis. MICROVASCULAR HEALTH SOLUTIONS
“The capillaries are protected by a micro-thin gel-layer called the endothelial glycocalyx,” reports Bob Long, CEO of Microvascular Health Solutions. “The only product clinically shown to restore, regenerate, and protect the glycocalyx is Endocalyx Pro.” MICROVASCULAR HEALTH SOLUTIONS
The study was overseen by University Hospital Munster in Germany and compared three groups: COVID-19 patients without need for mechanical ventilation COVID-19 patients requiring mechanical ventilation Control group of healthy people MICROVASCULAR HEALTH SOLUTIONS
"Up to 95% of the smallest capillaries —the tiniest part of microcirculation—have been severely damaged in patients on mechanical ventilators. For perspective, about 100 capillaries would fit inside a human hair." MICROVASCULAR HEALTH SOLUTIONS
“With Endocalyx Pro, it’s not too late to restore the endothelial glycocalyx,” says Long. “It’s estimated that over 80% of people of all ages are exposed to risks associated with breakdown of the microvascular system. Risk factors include aging, genetics, obesity, stress, pollution, smoking, vaping, and many additional risk factors.” MICROVASCULAR HEALTH SOLUTIONS
Get In Touch With Us Contact Us : 18002271933 Website : www.microvascular.com